Diligence memo · auto-generated · as of July 2, 2026

Vensun Pharmaceuticals, LLC

Vensun Pharmaceuticals, LLC looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Vensun Pharmaceuticals, LLC operates in Pharmaceuticals, based in NEWTOWN.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Vensun Pharmaceuticals, LLC has raised $1.6M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.6M on —.

Valuation (modeled)modeled

Provath models Vensun Pharmaceuticals, LLC at approximately $2.8M (range $1.2M–$4.3M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.06× the median modeled value of Seed Pharmaceuticals companies (335 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

No dated round to assess.

Comparablesmixed

Capital scale ranks ahead of 25% of Pharmaceuticals peers (1613 compared).

Modeled value ranks above 5% of those peers.

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.